Published in Curr Hypertens Rep on December 01, 2010
Prematurity-related hypertension in children and adolescents. Int J Pediatr (2012) 0.79
Hypertension in the teenager. Pediatr Clin North Am (2013) 0.79
Predictors of renal replacement therapy and mortality in children with chronic kidney disease. Saudi Med J (2015) 0.75
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens (2003) 5.94
Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med (2002) 5.72
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens (2009) 4.87
European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens (2013) 4.28
Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension (2009) 3.93
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens (2008) 3.32
Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens (2005) 3.15
Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens (2009) 3.13
Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens (2009) 2.68
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press (2013) 2.62
Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension (2008) 2.31
ESH position paper: renal denervation - an interventional therapy of resistant hypertension. J Hypertens (2012) 2.24
Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET). Hypertension (2012) 2.02
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
Carotid-femoral pulse wave velocity assessment by two different methods: implications for risk assessment. J Hypertens (2015) 1.98
Antihypertensive activity of angiotensin II AT1 receptor antagonists: a systematic review of studies with 24 h ambulatory blood pressure monitoring. J Hypertens (2007) 1.86
Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation (2011) 1.77
Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens (2011) 1.76
Blood pressure and obesity exert independent influences on pulse wave velocity in youth. Hypertension (2012) 1.70
Influence of concurrent obesity and low birth weight on blood pressure phenotype in youth. Hypertension (2009) 1.64
Prevalence, persistence, and clinical significance of masked hypertension in youth. Hypertension (2005) 1.61
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens (2014) 1.58
Associations of birth weight and postnatal weight gain with cardiometabolic risk parameters at 5 years of age. Hypertension (2014) 1.52
Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens (2012) 1.49
2016 European Guidelines on cardiovascular disease prevention in clinical practice. Rev Esp Cardiol (Engl Ed) (2016) 1.42
Regression of left ventricular hypertrophy and microalbuminuria changes during antihypertensive treatment. J Hypertens (2013) 1.39
[Renal function as a prognostic marker of mortality in heart failure]. Med Clin (Barc) (2009) 1.38
Blood pressure in chronic kidney disease stage 5D-report from a Kidney Disease: Improving Global Outcomes controversies conference. Kidney Int (2009) 1.16
Mycobacterium caprae infection in livestock and wildlife, Spain. Emerg Infect Dis (2011) 1.00
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study. J Hypertens (2013) 0.94
The impact of the degree of obesity on the discrepancies between office and ambulatory blood pressure values in youth. J Hypertens (2006) 0.93
Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension. J Hypertens (2012) 0.93
What the interventionalist should know about renal denervation in hypertensive patients: a position paper by the ESH WG on the interventional treatment of hypertension. EuroIntervention (2014) 0.92
Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population. PLoS One (2012) 0.92
Spatio-temporal trends of Iberian wild boar contact with Mycobacterium tuberculosis complex detected by ELISA. Ecohealth (2011) 0.92
European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions. J Hypertens (2009) 0.91
[ESH/ESC 2007 Guidelines for the management of arterial hypertension]. Rev Esp Cardiol (2007) 0.90
Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens (2007) 0.88
A database for animal tuberculosis (mycoDB.es) within the context of the Spanish national programme for eradication of bovine tuberculosis. Infect Genet Evol (2011) 0.87
Xanthine oxidoreductase polymorphisms: influence in blood pressure and oxidative stress levels. Pharmacogenet Genomics (2007) 0.86
Renin polymorphisms and haplotypes are associated with blood pressure levels and hypertension risk in postmenopausal women. J Hypertens (2008) 0.86
Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. J Hypertens (2006) 0.85
Evaluation of specificity of tuberculosis diagnostic assays in caprine flocks under different epidemiological situations. Res Vet Sci (2011) 0.85
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens (2014) 0.85
New developments in the pathogenesis of obesity-induced hypertension. J Hypertens (2015) 0.84
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire. J Hypertens (2010) 0.84
Association of a mineralocorticoid receptor gene polymorphism with hypertension in a Spanish population. Am J Hypertens (2009) 0.84
2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens (2016) 0.83
Updated ESH position paper on interventional therapy of resistant hypertension. EuroIntervention (2013) 0.83
Nocturnal blood pressure versus nondipping pattern: what do they mean? Hypertension (2007) 0.83
Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol (2012) 0.83
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke. J Hypertens (2016) 0.83
Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia. BMC Public Health (2010) 0.82
Polymorphisms of the UCP2 gene are associated with body fat distribution and risk of abdominal obesity in Spanish population. Eur J Clin Invest (2011) 0.82
Measurement of microalbuminuria--what the nephrologist should know. Nephrol Dial Transplant (2005) 0.81
Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension (2005) 0.81
The impact of birth weight on pulse pressure during adolescence. Blood Press Monit (2004) 0.81
Dietary polyunsaturated fatty acids may increase plasma LDL-cholesterol and plasma cholesterol concentrations in carriers of an ABCG1 gene single nucleotide polymorphism: study in two Spanish populations. Atherosclerosis (2011) 0.80
Prevalence and factors related to urinary albumin excretion in obese youths. J Hypertens (2013) 0.79
Genetic bases of urinary albumin excretion and related traits in hypertension. J Hypertens (2010) 0.79
European Society of Hypertension Working Group on Obesity: background, aims and perspectives. J Hypertens (2007) 0.79
The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2). Hypertens Res (2012) 0.79
[Practice guidelines 2007 for the treatment of arterial hypertension]. G Ital Cardiol (Rome) (2007) 0.79
Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials. J Hypertens (2016) 0.78
Survey of Spanish dentists on the prescription of antibiotics and antiseptics in surgery for impacted lower third molars. Med Oral Patol Oral Cir Bucal (2016) 0.78
Predictors of progression in hypertensive renal disease in children. J Clin Hypertens (Greenwich) (2004) 0.78
Different impacts of cardiovascular risk factors on oxidative stress. Int J Mol Sci (2011) 0.78
Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia. Metabolism (2009) 0.78
[Differences between office and ambulatory control of hypertension in very elderly patients. The CARDIORISC - MAPAPRES project]. Med Clin (Barc) (2009) 0.78
Urinary albumin excretion: lowering the threshold of risk in hypertension. Hypertension (2005) 0.77
Impaired exercise tolerance is associated with increased urine albumin excretion in the early stages of essential hypertension. Eur J Prev Cardiol (2011) 0.77
Sexual dimorphism in the transition from masked to sustained hypertension in healthy youths. Hypertension (2013) 0.77
Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study. Atherosclerosis (2010) 0.77
Reproducibility and validity of ambulatory blood pressure monitoring in children. Am J Hypertens (2002) 0.77
Microalbuminuria in essential hypertension: redefining the threshold. J Hypertens (2002) 0.77
Gender differences related to the presence of atrial fibrillation in older hypertensive patients. World J Cardiol (2013) 0.77
Nocturnal hypertension: will control of nighttime blood pressure prevent progression of diabetic renal disease? Curr Hypertens Rep (2004) 0.77
Risk factors associated with negative in-vivo diagnostic results in bovine tuberculosis-infected cattle in Spain. BMC Vet Res (2014) 0.77
Discordant response of glutathione and thioredoxin systems in human hypertension? Antioxid Redox Signal (2007) 0.76
Influence of obesity in central blood pressure. J Hypertens (2015) 0.76
Morning and smooth 24-h ambulatory blood pressure control is not achieved in general practice: results from the SURGE observational study. J Hypertens (2013) 0.76
Target blood pressure in elderly hypertensive patients and in patients with diabetes mellitus. J Hypertens (2014) 0.76
Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Pediatr Nephrol (2007) 0.75
[Limitations of blood pressure measurement outside the arm]. Med Clin (Barc) (2005) 0.75
New insights into urinary proteins as markers of cardiovascular risk in hypertension. J Hypertens (2006) 0.75
Reply. J Hypertens (2015) 0.75
Should we look for silent pulmonary embolism in patients with deep venous thrombosis? BMC Cardiovasc Disord (2014) 0.75
Microalbuminuria as an intermediate endpoint in essential hypertension: evidence is coming. J Hypertens (2004) 0.75
Necessity of add-on therapy in the treatment of hypertension: a new marker of high cardiovascular risk? J Hypertens (2012) 0.75
Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the European Society of Hypertension. J Hypertens (2016) 0.75
[2016 European Guidelines on cardiovascular disease prevention in clinical practice]. Kardiol Pol (2016) 0.75
Sympathetic neural activity, metabolic parameters and cardiorespiratory fitness in obese youths. J Hypertens (2016) 0.75